MedTrace Logo

Early Feasibility Study of the Percutaneous Osseointegrated Prosthesis (POP)

NCT02720159 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-03-25

No results posted yet for this study

Summary

The purpose of the clinical study is to characterize the efficacy and safety of a Percutaneous Osseointegrated Prosthesis (POP) device that can provide a satisfactory platform for direct skeletal attachment of prosthetic limbs, which includes a subdermal seal, thus allowing a proper biobarrier around the implant.

Conditions

  • Traumatic Amputee

Interventions

DEVICE

Percutaneous Osseintegrated Prosthesis

Sponsors & Collaborators

  • VA Salt Lake City Health Care System

    collaborator FED

  • Encore Medical, L.P.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02720159 on ClinicalTrials.gov